ALFA Finder
14:54 IST
BSE
Other Announcement
Titan Biotech Other Announcement
Titan Biotech Limited has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Titan Biotech Ltd
- Share price
- ₹376.95
- Market cap
- ₹1,947 Cr
- Revenue (annual)
- ₹206.2 Cr
- Net profit (annual)
- ₹29.89 Cr
- P/E (TTM)
- 50.4×Sector 35.5×
- Promoter holding
- 55.78%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Other Announcement 4Financial Results 4Board Meeting Date 4Bonus Issue 3Annual General Meeting 2Legal & Regulatory 1Dividend 1Debt & Borrowing 1Capital Structure Change 1Board Meeting Outcome 1Annual Report 1
Time
4 announcements with these filters
18:09 IST
BSE
Other Announcement
Titan Biotech Other Announcement
Titan Biotech has dispatched letters to shareholders with unregistered emails, providing web links to access the FY 2025-26 Annual Report and 34th AGM Notice.
12:25 IST
BSE
Other Announcement
Titan Biotech Other Announcement
Titan Biotech Limited has submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The report, issued by practicing company secretary Mr. Amit Anand, confirms the company's compliance with SEBI regulations and secretarial standards.
17:12 IST
BSE
Other Announcement
Titan Biotech Other Announcement
Titan Biotech Ltd submitted its quarterly compliance certificate under SEBI (Depositories and Participants) Regulations for the period ended March 31, 2026. The Registrar and Share Transfer Agent, Beetal Financial, confirmed that security certificates received for dematerialization were processed, cancelled, and substituted in the register of members within the mandated 15-day timeline.